Zobrazeno 1 - 10
of 137
pro vyhledávání: '"David R. Taft"'
Autor:
Suvarchala Kiranmai Avvari, Jaclyn A. Cusumano, Vamshi Krishna Jogiraju, Pooja Manchandani, David R. Taft
Publikováno v:
Pharmaceutics, Vol 15, Iss 11, p 2520 (2023)
In this investigation, PBPK modeling using the Simcyp® Simulator was performed to evaluate whether Roux-en-Y gastric bypass (RYGB) surgery impacts the oral absorption and bioavailability of azithromycin. An RYGB surgery patient population was adapte
Externí odkaz:
https://doaj.org/article/211fe0ba17194dfd9de8e08ecf547129
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1040 (2023)
Albendazole (ABZ) is a weakly basic drug that undergoes extensive presystemic metabolism after oral administration and converts to its active form albendazole sulfoxide (ABZ_SO). The absorption of albendazole is limited by poor aqueous solubility, an
Externí odkaz:
https://doaj.org/article/ff31cbb4e7bb495f88c9712a9ebf3a21
Publikováno v:
Current Drug Discovery Technologies. 17:387-396
Background: Lamivudine is a nucleoside reverse transcriptase inhibitor used to treat HIV and hepatitis B. It is primarily cleared by the kidney with renal secretion mediated by OCT2 and MATE. Objective: To use PBPK modeling to assess the impact of re
Autor:
Langguth, Peter
Publikováno v:
In European Journal of Pharmaceutics and Biopharmaceutics 2006 63(3):370-370
Publikováno v:
Journal of clinical pharmacologyReferences. 61(10)
Clinical studies in preterm neonates are rarely performed due to ethical concerns and difficulties associated with trials and recruitment. Consequently, dose selection in this population is primarily empirical. Scaling neonatal doses from adult doses
Autor:
Lisa Brown, Ann S. LaCasce, Linda Ho, Beth A. Christian, Chiyu Zhang, Nancy L. Bartlett, Ranjana H. Advani, Alex F. Herrera, Sahar Ansari, David R. Taft, Mariana Sacchi, Tatyana Feldman, Alison J. Moskowitz, Stephen M. Ansell, Julie M. Vose, Craig H. Moskowitz, Radhakrishnan Ramchandren
Publikováno v:
Blood. 138(6)
This phase 1-2 study evaluated brentuximab vedotin (BV) combined with nivolumab (Nivo) as first salvage therapy in patients with relapsed/refractory (r/r) classical Hodgkin lymphoma (cHL). In parts 1 and 2, patients received staggered dosing of BV an
Autor:
Hong Li, Clark Henderson, Christine O'Day, Phoenix A. Ho, Heather A. Van Epps, Changpu Yu, David R. Taft
Publikováno v:
Blood. 138:1197-1197
Patients with relapsed/triple class refractory (refractory to a proteasome inhibitor, immunomodulatory drug or anti-CD38 antibody) multiple myeloma (MM) have limited treatment options. Versatile therapies, such as unconjugated antibodies (Abs), that
Publikováno v:
Biopharmaceutics & Drug Disposition. 38:426-438
Pregnancy is associated with numerous physiological changes that influence absorption, distribution, metabolism and excretion. Moreover, the magnitude of these effects changes as pregnancy matures. For most medications, there is limited information a
Publikováno v:
Drug metabolism and pharmacokinetics. 37
Tizanidine is an alpha2-adrenergic agonist, used to treat spasticity associated with multiple sclerosis and spinal injury. Tizanidine is primarily metabolized by CYP1A2 and is considered a sensitive index substrate for this enzyme. The physiologicall
Publikováno v:
Pharmacology & Pharmacy. :43-55
The renal excretion of gentamicin, an aminoglycoside antibiotic, was studied in the isolated perfused rat kidney (IPRK) model. Dose-linearity experiments were carried out at four doses (400, 800, 1600, 3200 μg), targeting initial perfusate levels of